About Bioaffinity technologies
Bioaffinity technologies is a company based in San Antonio (United States) founded in 2014.. Bioaffinity technologies has raised $9.05 million across 6 funding rounds from investors including sanantonioedf. The company has 57 employees as of December 31, 2024. Bioaffinity technologies offers products and services including CyPath Lung and OncoSelect Therapeutics. Bioaffinity technologies operates in a competitive market with competitors including Cytek Biosciences, ACEA Biosciences, Accuri Cytometers, IntelliCyt and Orflo, among others.
- Headquarter San Antonio, United States
- Employees 57 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioaffinity Technologies, Inc.
-
Annual Revenue
$9.36 M269.68as on Dec 31, 2024
-
Net Profit
$-9.04 M-13.89as on Dec 31, 2024
-
EBITDA
$-8.35 M-8.08as on Dec 31, 2024
-
Total Equity Funding
$9.05 M (USD)
in 6 rounds
-
Latest Funding Round
$1.2 M (USD), Post-IPO
Aug 14, 2025
- Investors
-
Employee Count
57
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bioaffinity technologies
Bioaffinity technologies is a publicly listed company on the NASDAQ with ticker symbol BIAF in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bioaffinity technologies
Bioaffinity technologies offers a comprehensive portfolio of products and services, including CyPath Lung and OncoSelect Therapeutics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive test using flow cytometry for early lung cancer detection.
Research on cancer-selective therapies targeting tumor cells.
Unlock access to complete
Unlock access to complete
Funding Insights of Bioaffinity technologies
Bioaffinity technologies has successfully raised a total of $9.05M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.2 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $1.2M
-
First Round
First Round
(09 Mar 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Post-IPO - Bioaffinity technologies | Valuation |
investors |
|
| Aug, 2024 | Amount | Post-IPO - Bioaffinity technologies | Valuation |
investors |
|
| Mar, 2024 | Amount | Post-IPO - Bioaffinity technologies | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bioaffinity technologies
Bioaffinity technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include sanantonioedf. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides recruitment services to connect organizations with qualified candidates.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bioaffinity technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bioaffinity technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioaffinity Technologies Comparisons
Competitors of Bioaffinity technologies
Bioaffinity technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, ACEA Biosciences, Accuri Cytometers, IntelliCyt and Orflo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| domain | founded_year | HQ Location |
Instruments for life science research are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Compact flow cytometers for cell analysis are developed and provided.
|
|
| domain | founded_year | HQ Location |
Screening solutions are provided using bead-based and cell-based assays.
|
|
| domain | founded_year | HQ Location |
Instrumentation for cell and protein analysis is developed and marketed.
|
|
| domain | founded_year | HQ Location |
Offers technology for cell analysis, purification, and processing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bioaffinity Technologies
Frequently Asked Questions about Bioaffinity technologies
When was Bioaffinity technologies founded?
Bioaffinity technologies was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is Bioaffinity technologies located?
Bioaffinity technologies is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
Is Bioaffinity technologies a funded company?
Bioaffinity technologies is a funded company, having raised a total of $9.05M across 6 funding rounds to date. The company's 1st funding round was a Post-IPO of $2.62M, raised on Mar 09, 2017.
How many employees does Bioaffinity technologies have?
As of Dec 31, 2024, the latest employee count at Bioaffinity technologies is 57.
What is the annual revenue of Bioaffinity technologies?
Annual revenue of Bioaffinity technologies is $9.36M as on Dec 31, 2024.
What does Bioaffinity technologies do?
Bioaffinity Technologies was founded in 2014 in San Antonio, United States, within the biotechnology sector. Operations focus on designing diagnostic and therapeutic platforms for various cancers. In vitro diagnostics (IVD) are developed alongside targeting methods for cancer cells. The initial product, CyPath, utilizes a biolabel that induces fluorescence in cancer cells to enable detection. Activities emphasize early identification and treatment options in oncology.
Who are the top competitors of Bioaffinity technologies?
Bioaffinity technologies's top competitors include Cytek Biosciences, Accuri Cytometers and ACEA Biosciences.
What products or services does Bioaffinity technologies offer?
Bioaffinity technologies offers CyPath Lung and OncoSelect Therapeutics.
Is Bioaffinity technologies publicly traded?
Yes, Bioaffinity technologies is publicly traded on NASDAQ under the ticker symbol BIAF.
Who are Bioaffinity technologies's investors?
Bioaffinity technologies has 1 investor. Key investors include sanantonioedf.
What is Bioaffinity technologies's ticker symbol?
The ticker symbol of Bioaffinity technologies is BIAF on NASDAQ.